KY
Kyntra Bio, Inc. (KYNB)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$7.08
+0.71%
Mkt Cap $29.69M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $1.67M | $1.30M | -22.16% | -$3.89 | -$3.61 | +7.20% | — | — |
| Q4 2025 Nov 10, 2025 | $1.67M | $1.08M | -35.57% | -$4.01 | -$1.61 | +59.85% | — | — |
| Q3 2025 Aug 11, 2025 | $2.90M | $1.35M | -53.52% | -$2.25 | -$3.38 | -50.22% | — | — |
| Q2 2025 May 12, 2025 | $2.00M | $2.74M | +36.95% | $0.75 | -$4.00 | -633.33% | — | — |
| Q1 2025 Mar 17, 2025 | $24.91M | -$123.26M | -594.81% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q4 2024 Nov 12, 2024 | $20.23M | $46.33M | +129.09% | -$0.38 | -$0.17 | +55.26% | — | — |
| Q3 2024 Aug 6, 2024 | $34.66M | $50.64M | +46.11% | -$0.26 | -$0.16 | +38.46% | — | — |
| Q2 2024 May 6, 2024 | $36.67M | $55.90M | +52.45% | -$0.31 | -$0.33 | -6.45% | — | — |
| Q1 2024 Feb 26, 2024 | $38.90M | $27.14M | -30.24% | -$0.42 | -$0.57 | -35.71% | — | — |
| Q4 2023 Nov 6, 2023 | $39.29M | $40.13M | +2.15% | -$0.68 | -$0.52 | +23.53% | — | — |
| Q3 2023 Aug 7, 2023 | $34.74M | $44.32M | +27.57% | -$0.72 | -$0.65 | +9.72% | — | — |
| Q2 2023 May 8, 2023 | $31.84M | $36.16M | +13.57% | -$0.76 | -$0.81 | -6.58% | — | — |
| Q1 2023 Feb 27, 2023 | $23.97M | $34.37M | +43.38% | -$0.95 | -$0.70 | +26.32% | — | — |
| Q4 2022 Nov 7, 2022 | $31.62M | $15.73M | -50.24% | -$0.83 | -$0.98 | -18.07% | — | — |
| Q3 2022 Aug 8, 2022 | $36.16M | $29.81M | -17.57% | -$0.94 | -$0.78 | +17.02% | — | — |
| Q2 2022 May 9, 2022 | $28.76M | $60.83M | +111.51% | -$0.84 | -$0.68 | +19.05% | — | — |
| Q1 2022 Feb 28, 2022 | $47.65M | $16.54M | -65.28% | -$0.68 | -$1.45 | -113.24% | — | — |
| Q4 2021 Nov 9, 2021 | $132.92M | $155.97M | +17.34% | $0.01 | $0.54 | +9099.32% | — | — |
| Q3 2021 Aug 9, 2021 | $69.07M | $24.36M | -64.73% | -$0.48 | -$1.45 | -202.08% | — | — |
| Q2 2021 May 10, 2021 | $60.73M | $38.43M | -36.72% | -$0.90 | -$0.78 | +13.33% | — | — |